Matches in Wikidata for { <http://www.wikidata.org/entity/Q46849239> ?p ?o ?g. }
- Q46849239 description "2005 nî lūn-bûn" @default.
- Q46849239 description "2005年の論文" @default.
- Q46849239 description "2005年学术文章" @default.
- Q46849239 description "2005年学术文章" @default.
- Q46849239 description "2005年学术文章" @default.
- Q46849239 description "2005年学术文章" @default.
- Q46849239 description "2005年学术文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005年學術文章" @default.
- Q46849239 description "2005년 논문" @default.
- Q46849239 description "article científic" @default.
- Q46849239 description "article scientific" @default.
- Q46849239 description "article scientifique (publié 2005)" @default.
- Q46849239 description "articol științific" @default.
- Q46849239 description "articolo scientifico" @default.
- Q46849239 description "artigo científico (publicado na 2005)" @default.
- Q46849239 description "artigo científico (publicado na 2005)" @default.
- Q46849239 description "artigo científico" @default.
- Q46849239 description "artikull shkencor" @default.
- Q46849239 description "artikulong pang-agham" @default.
- Q46849239 description "artykuł naukowy" @default.
- Q46849239 description "artículo científico publicado en 2005" @default.
- Q46849239 description "artículu científicu" @default.
- Q46849239 description "bilimsel makale" @default.
- Q46849239 description "bài báo khoa học" @default.
- Q46849239 description "mokslinis straipsnis" @default.
- Q46849239 description "naučni članak" @default.
- Q46849239 description "scienca artikolo" @default.
- Q46849239 description "scientific article" @default.
- Q46849239 description "teaduslik artikkel" @default.
- Q46849239 description "tieteellinen artikkeli" @default.
- Q46849239 description "tudományos cikk" @default.
- Q46849239 description "vedecký článok" @default.
- Q46849239 description "vetenskaplig artikel" @default.
- Q46849239 description "videnskabelig artikel (udgivet 2005)" @default.
- Q46849239 description "vitenskapelig artikkel" @default.
- Q46849239 description "vitskapeleg artikkel" @default.
- Q46849239 description "vědecký článek" @default.
- Q46849239 description "wetenschappelijk artikel" @default.
- Q46849239 description "wissenschaftlicher Artikel" @default.
- Q46849239 description "επιστημονικό άρθρο" @default.
- Q46849239 description "мақолаи илмӣ" @default.
- Q46849239 description "мақолаи илмӣ" @default.
- Q46849239 description "наукова стаття, опублікована в грудні 2005" @default.
- Q46849239 description "научна статия" @default.
- Q46849239 description "научная статья" @default.
- Q46849239 description "научни чланак" @default.
- Q46849239 description "научни чланак" @default.
- Q46849239 description "գիտական հոդված" @default.
- Q46849239 description "מאמר מדעי" @default.
- Q46849239 description "سائنسی مضمون" @default.
- Q46849239 description "مقالة علمية" @default.
- Q46849239 description "مقالهٔ علمی" @default.
- Q46849239 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46849239 description "บทความทางวิทยาศาสตร์" @default.
- Q46849239 description "სამეცნიერო სტატია" @default.
- Q46849239 name "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 name "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 type Item @default.
- Q46849239 label "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 label "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 prefLabel "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 prefLabel "A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies" @default.
- Q46849239 P1433 Q46849239-AE667EF8-9595-434F-A4A8-E8588A3F65B6 @default.
- Q46849239 P1476 Q46849239-5DF8D49A-202C-4759-AF81-44A071A6D12C @default.
- Q46849239 P2093 Q46849239-002CB303-EB00-4B3C-B9C9-7835E4549E67 @default.
- Q46849239 P2093 Q46849239-0DBC39C4-08D4-45EB-BC11-7CFBE561CC6A @default.
- Q46849239 P2093 Q46849239-193DF644-4C27-4499-8F45-748BA3E5669F @default.
- Q46849239 P2093 Q46849239-2CEFA9BB-FF69-4A0D-8604-F201C6B66F7E @default.
- Q46849239 P2093 Q46849239-3C575488-6D7E-432C-81D0-296571E55933 @default.
- Q46849239 P2093 Q46849239-3CF57B35-4DFF-4D86-A6F6-E6C73FB525C7 @default.
- Q46849239 P2093 Q46849239-40B598CF-B635-46FD-974C-ED8C4A6AE725 @default.
- Q46849239 P2093 Q46849239-4B95197A-107D-4FE0-868B-0890765213E0 @default.
- Q46849239 P2093 Q46849239-556F2C50-8993-421C-8FE3-B188621E0ED4 @default.
- Q46849239 P2093 Q46849239-6442E78A-8D07-443F-AD1D-742766DFD14F @default.
- Q46849239 P2093 Q46849239-782E1568-E42B-4996-83BC-92C328369F2F @default.
- Q46849239 P2093 Q46849239-8202C61A-DC19-483E-82B3-B4E045B5EC0C @default.
- Q46849239 P2093 Q46849239-A58E540A-C635-4844-8B25-3CC0F4A5DCC3 @default.
- Q46849239 P2093 Q46849239-AAFFBC54-5545-4DB7-B57A-5BB9501900AF @default.
- Q46849239 P2093 Q46849239-B0EB984F-9E82-4FDC-B451-DCA1A7AA9286 @default.
- Q46849239 P2093 Q46849239-B9C1EF2D-6FD7-41C5-A910-AD0BA6CC867D @default.
- Q46849239 P2093 Q46849239-BEAF060D-E5A8-4ED6-BA60-F859E12C7E73 @default.
- Q46849239 P2093 Q46849239-E8B93E72-34C0-495F-BC8B-C95D90752A4B @default.
- Q46849239 P2093 Q46849239-F363BAC4-AA4C-4FD8-9DB5-6E23A0A77E1D @default.
- Q46849239 P2093 Q46849239-FAF2A860-80AD-4F66-ADAB-66541C3EE631 @default.
- Q46849239 P2860 Q46849239-26408EE7-851F-4E55-803B-3329AA06F910 @default.
- Q46849239 P2860 Q46849239-3B0DFE1E-557D-40E8-8055-70222A104942 @default.
- Q46849239 P2860 Q46849239-3EB77315-6776-4CFE-BBC0-B9CFD4A32206 @default.
- Q46849239 P2860 Q46849239-47EDDFF6-B035-4FF0-92AE-9A4B53A7AC5C @default.
- Q46849239 P2860 Q46849239-4E0310AF-936D-4315-8635-AF75E2F27514 @default.
- Q46849239 P2860 Q46849239-541D9E96-516C-431A-A64D-B6C0C5337AF2 @default.
- Q46849239 P2860 Q46849239-584E0742-1290-4971-A1B6-2419BF4C66B7 @default.
- Q46849239 P2860 Q46849239-5ABD7163-B025-42A7-B77D-7C77ADA3C7E9 @default.
- Q46849239 P2860 Q46849239-5D5AB8AA-E66D-4F0B-884E-C4EB2A823347 @default.
- Q46849239 P2860 Q46849239-6E3C26A8-A95D-45F8-8E00-6B371CDF2E03 @default.
- Q46849239 P2860 Q46849239-709234DB-1762-43B6-9942-39B66D835436 @default.